Quick Answer
NANOVIRICIDES, INC. reported Operating Income of -$9.59 million for fiscal year 2025.
NANOVIRICIDES, INC. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$9.59M | -12.6% |
| 2024 | -$8.52M | +4.8% |
| 2023 | -$8.94M | -10.2% |
| 2022 | -$8.11M | +7.2% |
| 2021 | -$8.74M | -9.3% |
| 2020 | -$8.00M | +7.7% |
| 2019 | -$8.66M | +7.1% |
| 2018 | -$9.33M | +2.9% |
| 2017 | -$9.60M | -8.4% |
| 2016 | -$8.86M | -25.4% |
| 2015 | -$7.06M | +18.5% |
| 2014 | -$8.67M | -31.5% |
| 2013 | -$6.59M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | -$2.23M | -8.5% | -24.3% |
| September 30, 2025 | -$1.80M | +43.3% | +20.1% |
| March 31, 2025 | -$2.25M | -17.9% | -9.2% |
| December 31, 2024 | -$2.06M | +5.8% | +35.0% |
| September 30, 2024 | -$3.17M | -55.9% | -66.0% |
| March 31, 2024 | -$1.91M | -5.4% | +12.6% |
| December 31, 2023 | -$2.18M | -19.1% | -7.5% |
| September 30, 2023 | -$2.03M | -25.2% | -12.2% |
- NANOVIRICIDES, INC. showed a decrease of -12.6% in Operating Income compared to the prior fiscal year.
- Over the 2013–2025 period, NANOVIRICIDES, INC.’s operating income has declined by 45.5% (from -$6.59 million to -$9.59 million).
- The most recent figure is from NANOVIRICIDES, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on September 29, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: